文献速递创伤与烧伤重症综合管理与镇静镇痛复苏、休克与脓毒症

严重横纹肌溶解对重症监护创伤患者30天死亡率的影响:Traumabase登记处的倾向性评分分析

Evaluation of severe rhabdomyolysis on day 30 mortality in trauma patients admitted to intensive care: a propensity score analysis of the Traumabase registry.
PubMed 文献 · Crit Care · 2024-11-22
一句话结论在整体创伤ICU人群中,严重横纹肌溶解(CK>5000 U/L)与30天死亡率无关;但在合并失血性休克患者中,其与30天死亡率绝对增加4.0%相关。

本研究为在法国开展的多中心队列研究,基于国家重大创伤登记处Traumabase(2012年1月1日至2023年7月1日),纳入所有收治于参与中心ICU且测量了CK的创伤患者,共8592例,其中1544例(18.0%)存在严重横纹肌溶解(CK>5000 U/L)。采用倾向性评分及逆处理概率加权双重稳健方法计算处理组的平均处理效应(ATT)。整体队列中ATT(风险差)为0.073[-0.054至0.200];失血性休克亚组(1311例)ATT为0.039[0.014至0.063];颅脑创伤亚组未见死亡效应。严重横纹肌溶解与更严重的创伤及更多ICU并发症相关,多器官衰竭所致死亡(39.9% vs 12.4%)和脓毒性休克所致死亡(2.6% vs 0.8%)在严重横纹肌溶解患者中更常见。

要点

  • 整体创伤ICU队列中,严重横纹肌溶解(CK>5000 U/L)对30天死亡率的ATT为0.073[-0.054至0.200],未达统计学显著。
  • 合并失血性休克的创伤患者中,严重横纹肌溶解与30天死亡率绝对增加4.0%相关(ATT 0.039[0.014至0.063])。
  • 颅脑创伤亚组中,严重横纹肌溶解对30天死亡率未见效应。
  • 严重横纹肌溶解患者多器官衰竭所致死亡占39.9%,高于无严重横纹肌溶解者的12.4%;脓毒性休克所致死亡占2.6%,高于0.8%。
  • 严重横纹肌溶解与更严重的创伤及更多ICU并发症相关,无论是否与肾功能相关。

适用人群与场景

  • 2012年1月1日至2023年7月1日期间,法国参与中心收治于ICU且测量了CK的创伤患者。
  • 共纳入8592例,其中1544例(18.0%)存在严重横纹肌溶解(CK>5000 U/L)。
  • 亚组分析包括失血性休克亚组(1311例)和颅脑创伤亚组。

诊断标准与关键阈值

  • 严重横纹肌溶解定义为肌酸激酶(CK)>5000 U/L。

研究设计与关键结果

  • 研究类型:基于Traumabase国家重大创伤登记处的多中心队列研究,采用倾向性评分及逆处理概率加权双重稳健方法计算平均处理效应(ATT)。
  • 严重横纹肌溶解患者特征:男性78.6%,中位[IQR]年龄41[27-58]岁,ISS 20[13-29],钝性创伤占90.8%。
  • 整体队列中,ATT(风险差)为0.073[-0.054至0.200]。
  • 失血性休克亚组(1311例)中,ATT为0.039[0.014至0.063]。
  • 颅脑创伤亚组中,严重横纹肌溶解对30天死亡率未见效应。
  • 严重横纹肌溶解与更严重的创伤及更多ICU并发症相关(无论是否与肾功能相关)。
  • 多器官衰竭所致死亡:严重横纹肌溶解组39.9% vs 无严重横纹肌溶解组12.4%。
  • 脓毒性休克所致死亡:严重横纹肌溶解组2.6% vs 无严重横纹肌溶解组0.8%。

证据类型、等级与局限

  • 证据类型:多中心队列研究(基于Traumabase登记处),采用倾向性评分和逆处理概率加权分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在整体创伤ICU人群中,严重横纹肌溶解(CK>5000 U/L)未显示与30天死亡率独立相关。
  • 在合并失血性休克的创伤患者中,严重横纹肌溶解与30天死亡率绝对增加4.0%相关,提示该亚组可能需更密切监护。
  • 严重横纹肌溶解与ICU并发症(包括多器官衰竭和脓毒性休克所致死亡)增加相关,应关注ICU期间并发症的预防与处理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic rhabdomyolysis (RM) is common and associated with the development of acute kidney injury and potentially with other organ dysfunctions. Thus, RM may increase the risk of death. The primary objective was to assess the effect of severe RM (Creatine Kinase [CK] > 5000 U/L) on 30-day mortality in trauma patients using a causal inference approach.

METHODS: In this multicenter cohort study conducted in France using a national major trauma registry (Traumabase) between January 1, 2012, and July 1, 2023, all patients admitted to a participating major trauma center hospitalized in intensive care unit (ICU) and with CK measurement were included. Confounding variables for both 30-day mortality and exposure were used to establish a propensity score. A doubly robust approach with inverse treatment weighting enabled the calculation of the average treatment effect on the treated (ATT). Analyses were performed in the overall cohort as well as in two subgroups: hemorrhagic shock subgroup (HS) and traumatic brain injury subgroup (TBI). Sensitivity analyses were conducted.

RESULTS: Among the 8592 patients included, 1544 (18.0%) had severe RM. They were predominantly males (78.6%) with median [IQR] age of 41 [27-58] years and severely injured (ISS 20 [13 - 29]) mainly from blunt trauma (90.8%). In the entire cohort, the ATT, expressed as a risk difference, was 0.073 [-0.054 to 0.200]. Considering the 1311 patients in the HS subgroup, the ATT was 0.039 [0.014 to 0.063]. As in the overall cohort, there was no effect on mortality in the TBI subgroup. Severe RM was associated with greater severity of trauma and more complications (whether related to renal function or not) during the ICU stay. Mortality due to multiorgan failure (39.9% vs 12.4%) or septic shock (2.6% vs 0.8%) was more frequent among patients with severe RM.

CONCLUSIONS: Severe RM was not associated with 30-day mortality considering the overall cohort. However, it was associated with a 4.0% increase in 30-day mortality among patients with concurrent hemorrhagic shock. Severe RM plays a significant role in ICU morbidity.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Martinez T, Harrois A, Codorniu A, et al. Evaluation of severe rhabdomyolysis on day 30 mortality in trauma patients admitted to intensive care: a propensity score analysis of the Traumabase registry. Crit Care. 2024. PMID: 39578880. doi:10.1186/s13054-024-05158-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。